Evidence map›Paper›PMID 20357951›Full record

ReviewCanadian journal of veterinary research = Revue canadienne de recherche veterinaire2010

Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.

André G Buret

Abstract readReview
In one paragraph

Review in Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Methaphylactic effect of tulathromycin treatment on rumen fluid parameters in feedlot beef cattle.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2016
    Trial
  3. Effect of spiramycin and tulathromycin on abomasal emptying rate in milk-fed calves.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2014
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-ResistantInternational journal of molecular sciences · 2023
    Article
  10. Review
  11. Article
  12. Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Effect of fosfomycin,Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

André G BuretInflammation Research Network, Department of Biological Sciences, 2500 University Drive, University of Calgary, Calgary, Alberta. aburet@ucalgary.ca
Research Network (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exaggerated immune responses, such as those implicated in severe inflammatory reactions, are costly to the metabolism. Inflammation and pro-inflammatory mediators negatively affect production in the food animal industry by reducing growth, feed intake, reproduction, milk production, and metabolic health. An ever-increasing number of findings have established that antibiotics, macrolides in particular, may generate anti-inflammatory effects, including the modulation of pro-inflammatory cytokines and the alteration of neutrophil function. The effects are time- and dose-dependent, and the mechanisms responsible for these phenomena remain incompletely understood. Recent studies, mostly using the veterinary macrolide tilmicosin, may have shed new light on the mode of action of some macrolides and their anti-inflammatory properties. Indeed, research findings demonstrate that this compound, amongst others, induces neutrophil apoptosis, which in turn provides anti-inflammatory benefits. Studies using tilmicosin model systems in vitro and in vivo demonstrate that this antibiotic has potent immunomodulatory effects that may explain why at least parts of its clinical benefits are independent of anti-microbial effects. More research is needed, using this antibiotic and others that may have similar properties, to clarify the biological mechanisms responsible for antibiotic-induced neutrophil apoptosis, and how this, in turn, may provide enhanced clinical benefits. Such studies may help establish a rational basis for the development of novel, efficacious, anti-microbial compounds that generate anti-inflammatory properties in addition to their antibacterial effects.

Indexed as

AnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsApoptosisHumansImmunomodulationNeutrophilsTylosinAnti-Bacterial AgentsAnti-Inflammatory AgentstilmicosinTylosin

Identifiers

PMID20357951
PMCPMC2801304
OpenAlexW36739683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.